Interview, Fireside Chat
A Conversation with SoftBank Vision Fund CEO Rajeev Misra
- Digital adoption accelerates industry-specific behavioral shifts by years, with food delivery systems and online grocery sectors projected to disrupt global supply chains by removing real estate and multiple middlemen layers to reduce costs.
- Digital finance is forecast to become increasingly frictionless, improving credit access for small merchants and SMEs through payment data and new card issuers that bypass lengthy KYC processes, while interchange costs decrease.
- Technology is expected to equalize educational opportunities within the next two years, while pharmaceutical R&D costs are predicted to fall as smaller biotech firms utilize genome data to challenge the monopolistic power of large drugmakers.
- Geopolitical tensions and election cycles are anticipated to degrade global cooperation in R&D and scale, prompting large economies like the U.S., China, and Europe to prioritize self-sufficiency in technology, healthcare, and 5G infrastructure over shared knowledge.
- The manufacturing model is shifting from centralized mass production to geographically dispersed facilities to create redundancies, a change expected to increase overall costs.
- Strategic focus in the Vision Fund portfolio is narrowing to approximately three core areas per company to reduce burn rates, while SoftBank Group and the fund are conserving cash runways for 18 to 24 months to endure a potential prolonged crisis.
- Technology innovation is projected to shift with Asian markets leading the development of low-cost telecom and financial services that the West will subsequently adopt.
- The post-globalization economic landscape is characterized by a "winner takes all" dynamic in technology, where resilient portfolio companies are expected to survive the crisis, acquire assets cheaply, and expand.
- Risks include strained international cooperation on chip and medical technologies, fears regarding vaccine sharing if developed in China first, and the potential decline of research collaboration due to political climate and the race for self-sufficiency in vaccines and medical devices.